596 related articles for article (PubMed ID: 28648941)
1. Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features.
Mohamed M; Fisher C; Thway K
Ann Diagn Pathol; 2017 Jun; 28():60-67. PubMed ID: 28648941
[TBL] [Abstract][Full Text] [Related]
2. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.
Arbajian E; Puls F; Magnusson L; Thway K; Fisher C; Sumathi VP; Tayebwa J; Nord KH; Kindblom LG; Mertens F
Am J Surg Pathol; 2014 Jun; 38(6):801-8. PubMed ID: 24441665
[TBL] [Abstract][Full Text] [Related]
3. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
4. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases.
Prieto-Granada C; Zhang L; Chen HW; Sung YS; Agaram NP; Jungbluth AA; Antonescu CR
Genes Chromosomes Cancer; 2015 Jan; 54(1):28-38. PubMed ID: 25231134
[TBL] [Abstract][Full Text] [Related]
5. Sclerosing epithelioid fibrosarcoma.
Patterson JW; Tchernev G; Chokoeva AA; Wick MR
Wien Med Wochenschr; 2017 Apr; 167(5-6):120-123. PubMed ID: 27631873
[TBL] [Abstract][Full Text] [Related]
6. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.
Guillou L; Benhattar J; Gengler C; Gallagher G; Ranchère-Vince D; Collin F; Terrier P; Terrier-Lacombe MJ; Leroux A; Marquès B; Aubain Somerhausen Nde S; Keslair F; Pedeutour F; Coindre JM
Am J Surg Pathol; 2007 Sep; 31(9):1387-402. PubMed ID: 17721195
[TBL] [Abstract][Full Text] [Related]
7. Primary Renal Hybrid Low-grade Fibromyxoid Sarcoma-Sclerosing Epithelioid Fibrosarcoma: An Unusual Pediatric Case With EWSR1-CREB3L1 Fusion.
Mok Y; Pang YH; Sanjeev JS; Kuick CH; Chang KT
Pediatr Dev Pathol; 2018; 21(6):574-579. PubMed ID: 29426275
[TBL] [Abstract][Full Text] [Related]
8. Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.
Puls F; Agaimy A; Flucke U; Mentzel T; Sumathi VP; Ploegmakers M; Stoehr R; Kindblom LG; Hansson M; Sydow S; Arbajian E; Mertens F
Am J Surg Pathol; 2020 May; 44(5):594-606. PubMed ID: 31913156
[TBL] [Abstract][Full Text] [Related]
9. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
[TBL] [Abstract][Full Text] [Related]
10. Sclerosing Epithelioid Fibrosarcoma: A Distinct Sarcoma With Aggressive Features.
Warmke LM; Meis JM
Am J Surg Pathol; 2021 Mar; 45(3):317-328. PubMed ID: 32769431
[TBL] [Abstract][Full Text] [Related]
11. Sclerosing Epithelioid Fibrosarcoma.
Warmke LM; Yu W; Meis JM
Surg Pathol Clin; 2024 Mar; 17(1):119-139. PubMed ID: 38278601
[TBL] [Abstract][Full Text] [Related]
12. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
[TBL] [Abstract][Full Text] [Related]
13. Sclerosing epithelioid fibrosarcoma - a report of two cases with cytogenetic analysis of FUS gene rearrangement by FISH technique.
Rekhi B; Folpe AL; Deshmukh M; Jambhekar NA
Pathol Oncol Res; 2011 Mar; 17(1):145-8. PubMed ID: 20499220
[TBL] [Abstract][Full Text] [Related]
14. Low-grade fibromyxoid sarcoma of the breast: genetic characterization and immunohistochemical comparison to morphologic mimics.
Cloutier JM; Moreland A; Wang L; Kunder CA; Allard G; Wang A; Krings G; Charville GW; Bean GR
Hum Pathol; 2023 Sep; 139():17-26. PubMed ID: 37392946
[TBL] [Abstract][Full Text] [Related]
15. Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.
Matsuyama A; Hisaoka M; Shimajiri S; Hayashi T; Imamura T; Ishida T; Fukunaga M; Fukuhara T; Minato H; Nakajima T; Yonezawa S; Kuroda M; Yamasaki F; Toyoshima S; Hashimoto H
Am J Surg Pathol; 2006 Sep; 30(9):1077-84. PubMed ID: 16931951
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular characterization of primary sclerosing epithelioid fibrosarcoma of bone and review of the literature.
Tsuda Y; Dickson BC; Dry SM; Federman N; Suurmeijer AJH; Swanson D; Sung YS; Zhang L; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2020 Apr; 59(4):217-224. PubMed ID: 31675134
[TBL] [Abstract][Full Text] [Related]
17. EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of low-grade fibromyxoid sarcoma.
Lau PP; Lui PC; Lau GT; Yau DT; Cheung ET; Chan JK
Am J Surg Pathol; 2013 May; 37(5):734-8. PubMed ID: 23588368
[TBL] [Abstract][Full Text] [Related]
18. Metastatic Sclerosing Epithelioid Fibrosarcoma in Bone Marrow.
Asakra R; Zaidi S; Thway K
Int J Surg Pathol; 2017 Dec; 25(8):702-704. PubMed ID: 28697683
[TBL] [Abstract][Full Text] [Related]
19. In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment Targets.
Arbajian E; Puls F; Antonescu CR; Amary F; Sciot R; Debiec-Rychter M; Sumathi VP; Järås M; Magnusson L; Nilsson J; Hofvander J; Mertens F
Clin Cancer Res; 2017 Dec; 23(23):7426-7434. PubMed ID: 28939748
[No Abstract] [Full Text] [Related]
20. Sclerosing epithelioid fibrosarcoma of bone: morphological, immunophenotypical, and molecular findings of 9 cases.
Kosemehmetoglu K; Ardic F; Kilpatrick SE; Aydingoz U; Sumathi VP; Michal M
Virchows Arch; 2021 Apr; 478(4):767-777. PubMed ID: 33084978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]